Lupin Limited — Updates, 26-02-2026: Press Release (Revised)
26-02-2026 | 08:42 pm
26-02-2026 | 08:42 pm
Lupin's CEO, Vinita Gupta, made the CNBC Changemakers list. Her leadership drove Lupin to become the 3rd largest US generic supplier, gaining key biosimilar FDA approval, and expanding US manufacturing with a new Florida inhalation facility. Strong US growth focus.
No comments yet. Be the first to comment!
